President Donald Trump signed an executive order on the healthcare sector yesterday, aiming to lower prescription drug prices for Americans,

President Donald Trump wants Congress to change a policy that gives certain drugs longer protection from drug price negotiations in Medicare, a fix that could address one of the drug industry’s top complaints with the Biden-era law.

The order calls for lowering the price of insulin for low-income patients or people who are uninsured, as well as lowering the price of injectable epinephrine.